...
首页> 外文期刊>The Professional Medical Journal >HCV AND HBV INFECTION WITH A COMPARATIVE STUDY TO ASSESS THE POOR PROGNOSTIC FACTORS AND IN-HOSPITAL MORTALITY RATE
【24h】

HCV AND HBV INFECTION WITH A COMPARATIVE STUDY TO ASSESS THE POOR PROGNOSTIC FACTORS AND IN-HOSPITAL MORTALITY RATE

机译:评估HCV和HBV感染的不良预后因素和住院死亡率的比较研究

获取原文

摘要

Objectives: The aim behind this study was to scientifically assess the poor prognostic factors and in-hospital mortality rate in patients infected with HCV and HBV infection with liver cirrhosis. Study Design: Comparative hospital based study. Setting: Gastroenterology and hepatology dedicated center, Asian Institute of Medical Sciences (AIMS), Hyderabad. Period: Thirty one months from 1 st October 2012 to 31 st May 2015. Patients and Methods: 419 participants between the ages of 20 to 80 years including both male and female and diagnosed either with HCV or HBV infection along with cirrhosis were included. Data were entered and analyzed by using Statistical Package for the Social Sciences version 20.0. Results: Out of total 419 patients, the mean age and S.D. of HBV patients were 41.21 ± 11.77 and HCV patients were 50.44 ± 10.07 years. The overall mortality rate was 11.69% (N = 49) among them patients with of HBV infection had a comparatively higher mortality rate than patients with HCV infection, 13.07% and 11.07%, respectively. The most common risk factors observed in our study were Hepatorenal syndrome (41.17%) in HCV cirrhotics and hematemesis (34.37%) in HCV cirrhotic patients. Conclusion: Our study shows that overall mortality is greater in HBV cirrhotic patients than with HCV cirrhotics. Poor in-hospital mortality factors vary in both HBV and HCV related cirrhotic patients and this discrepancy in the observation is universally observed.
机译:目的:这项研究的目的是科学评估感染HCV和HBV合并肝硬化的患者的不良预后因素和院内死亡率。研究设计:基于比较医院的研究。地点:海得拉巴亚洲医学科学研究所(AIMS)胃肠病和肝病专科中心。时间:2012年10月1日至2015年5月31日,共31个月。患者和方法:419名年龄在20至80岁之间的参与者,包括男性和女性,被诊断患有HCV或HBV感染并伴有肝硬化。使用统计软件包(社会科学版本20.0)输入和分析数据。结果:在总共419名患者中,平均年龄和S.D.。 HBV患者的年龄为41.21±11.77岁,HCV患者的年龄为50.44±10.07岁。总体死亡率为11.69%(N = 49),其中HBV感染患者的死亡率高于HCV感染患者,分别为13.07%和11.07%。在我们的研究中观察到的最常见的危险因素是HCV肝硬化患者的肝肾综合征(41.17%)和HCV肝硬化患者的呕血(34.37%)。结论:我们的研究表明,HBV肝硬化患者的总死亡率要高于HCV肝硬化患者。在HBV和HCV相关的肝硬化患者中,院内死亡率差的因素各不相同,这种差异普遍存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号